Reneo Pharmaceuticals Inc (RPHM)
1.89
-0.01
(-0.53%)
USD |
NASDAQ |
May 21, 16:00
1.89
0.00 (0.00%)
After-Hours: 17:14
Reneo Pharmaceuticals Cash from Investing (TTM): 5.772M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 5.772M |
December 31, 2023 | 10.52M |
September 30, 2023 | -56.17M |
June 30, 2023 | -122.86M |
March 31, 2023 | -44.76M |
December 31, 2022 | -57.84M |
September 30, 2022 | -22.77M |
Date | Value |
---|---|
June 30, 2022 | 18.15M |
March 31, 2022 | -17.92M |
December 31, 2021 | -23.38M |
September 30, 2021 | -31.54M |
June 30, 2021 | -25.84M |
March 31, 2021 | 2.152M |
December 31, 2020 | 7.376M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-122.86M
Minimum
Jun 2023
18.15M
Maximum
Jun 2022
-25.65M
Average
-23.07M
Median
Cash from Investing (TTM) Benchmarks
Mirum Pharmaceuticals Inc | -134.23M |
NovaBay Pharmaceuticals Inc | 1.062M |
Palatin Technologies Inc | 9.41M |
iBio Inc | 1.044M |
Theriva Biologics Inc | -0.194M |